| 引用本文: | 耿晓婷,陶巧凤,楼永军,郑金琪,唐登峰,王绯,潘芳芳,郑成,朱价.《欧洲药典》凡例的主要内容介绍[J].中国现代应用药学,2024,41(23):122-121. |
| Geng Xiaoting,Tao Qiaofeng,Lou Yongjun,Zheng Jinqi,Tang Dengfeng,Wang Fei,Pan Fangfang,Zheng Cheng,Zhu Jia.Introduction of the main content of the General Notices in the European pharmacopoeia[J].Chin J Mod Appl Pharm(中国现代应用药学),2024,41(23):122-121. |
|
| 本文已被：浏览 9次 下载 11次 |
码上扫一扫！ |
|
|
| 《欧洲药典》凡例的主要内容介绍 |
|
耿晓婷1, 陶巧凤1, 楼永军1, 郑金琪1, 唐登峰1, 王绯2, 潘芳芳1, 郑成1, 朱价1
|
|
1.浙江省食品药品检验研究院;2.国家药典委员会
|
|
| 摘要: |
| 目的 对《欧洲药典》11.0版凡例的主要内容及相较10.0版的变化内容进行介绍，并对其中具有借鉴意义的部分进行分析。方法 比较《欧洲药典》11.0版与10.0版凡例的编排结构与内容，对变化和重点内容进行评述。结果 与《欧洲药典》10.0版比较，11.0版凡例的编排结构和内容均有明显变化，增加了各论适用性说明、总论和制剂总论、草药各论和化学药品各论的相关要求等内容，并对部分定义进行规范化修订。结论 《欧洲药典》11.0版凡例的编排结构更为清晰，内容更为严谨全面，对《欧洲药典》的实施具有重要的指导意义，可供《中国药典》凡例的修订参考。 |
| 关键词: 欧洲药典 凡例 进展 质量 质量标准 |
| DOI： |
| 分类号:R921.3 |
| 基金项目:国家药典委员会药品标准制修订研究课题 (2023Y18) |
|
| Introduction of the main content of the General Notices in the European pharmacopoeia |
|
Geng Xiaoting1, Tao Qiaofeng1, Lou Yongjun1, Zheng Jinqi1, Tang Dengfeng1, Wang Fei2, Pan Fangfang1, Zheng Cheng1, Zhu Jia1
|
|
1.Zhejiang Institute For Food and Drug Control;2.Chinese Pharmacopoeia Commission
|
| Abstract: |
| ABSTRACT: OBJECTIVE To introduce the main and changing content of the General Notices in the 11.0 edition of European pharmacopoeia compared with the 10.0 edition, and to compare and analyze the content with reference significance. METHODS To compare the layout structure and main content of the General Notices in the 11.0 edition of European pharmacopoeia with the 10.0 edition, and to comment on changes and key content of the 11.0 edition of General Notices. RESULTS Compared with the 10.0 edition, the layout structure and content of the 11.0 edition of General Notices had changed significantly. And it supplemented the contents of demonstration of suitability of monographs, general monographs and general monographs on dosage forms, monographs on herbal drugs, monographs on medicinal active substance, etc. Furthermore, it normalized some definitions. CONCLUSION The layout structure of the new version of the General Notices is more clear, the content is more rigorous and comprehensive, and it has guiding significance for the implementation of European pharmacopoeia, and can be used as reference for the revision of the General Notices in the Chinese Pharmacopoeia. |
| Key words: european pharmacopoeia general notices progress quality quality specification |
